PDCA管理在降低高渗性药物输液致静脉炎中的应用效果

Application effect of PDCA management in reducing the high osmotic drug infusion phlebitis

目的探讨PDCA管理在降低高渗性药物输液致静脉炎中的应用效果。方法选取2015年1~6月在广州医科大学附属清远市人民医院(以下简称"我院")消化内科接受高渗性药物输液的2880人次作为对照组(活动前),采用常规输液治疗方法;选取2015年7~12月在我院消化内科接受高渗性药物输液的2977人次作为观察组(活动后),成立PDCA管理活动小组进行干预。比较分析开展PDCA管理活动前后的高渗性药物发生静脉炎情况和患者对护理服务满意度。结果开展PDCA活动后,高渗性药物输液致静脉炎发生率由4.20%降为1.55%,差异有统计学意义(P<0.05);患者对护理服务满意度由80.00%提高到94.00%,差异有统计学意义(P<0.05)。结论 PDCA活动能进一步规范高渗性药物输液的合理使用,降低静脉炎的发生率,提高患者对护理服务满意度,提升团队成员的个人能力。

Objective To explore the： application effect of PDCA management in reducing the phlebitis caused by hypertonic drugs infusion. Methods From January to June 2015, 2880 cases accepted hyperosmotie drugs infusion in Department of Gastroenterology （＂our hospital＂ for short ） were selected as control group （before activity）, who were treated by conventional infusion. And from July to December of 2015, 2977 cases accepted hyperosmotie drugs infusion in our hospital Department of Gastroenterology were selected as observation group （after activity）, who were treated by PDCA management. The occurrence of hyperosmotic drugs phlebitis and the nursing service satisfaction of patients before and after PDCA management activity were analyzed and compared. Results The incidence of phlebitis induced by hyperosmotie drugs infusion reduced 4.20% to 1.55% after PDCA activity, the difference was statistically significant （P 〈 0.05）; the nursing service satisfaction of patients from 80.00% upgrade to 94.00%, the difference was statistically significant （P 〈 0.05）. Conclusion PDCA activity can regulate the rational usage of hypertonic drug infusion, reduce the incidence of phlebitis, improve the nursing service satisfaction of patients, and enhance the ability of the team members.